The Future of Ketamine and Temper Disorders In 2019, the FDA and European Fee authorized the use of an esketamine nasal spready beneath the brand name title Spravato to deal with despair. However, as of 2021, ketamine hasn't been accredited by the FDA to deal with despair or other mental wellbeing disorders, and thus, the medication is getting used